TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pensa Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/03 | 2021/12 | 2020/12 |
Turnover |
21,128
|
28,535
|
16,630 |
Financial expenses |
67
|
1
|
104 |
Earnings before taxes |
-2,447
|
782
|
325 |
EBITDA |
-2,200
|
732
|
438 |
Total assets |
18,895
|
21,173
|
26,132 |
Current assets |
14,869
|
12,888
|
19,866 |
Current liabilities |
6,785
|
5,083
|
10,107 |
Equity capital |
12,111
|
16,089
|
16,025 |
- share capital |
661
|
727
|
741 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/03 | 2021/12 | 2020/12 |
Solvency |
64.1%
|
76.0%
|
61.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
-11.6%
|
2.7%
|
2.0% |
Return on assets (ROA) |
-12.6%
|
3.7%
|
1.6% |
Current ratio |
219.1%
|
253.6%
|
196.6% |
Return on equity (ROE) |
-20.2%
|
4.9%
|
2.0% |
Change turnover |
-4,796
|
12,219
|
1,934 |
Change turnover % |
-19%
|
75%
|
13% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/03 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.